ATG4D and cancer: The activity of miR-125b1 in this circumstance contributed to inhibition of autophagy through ATG4D. In other cancers, ATG4D was found to be a direct target of miR-101 and its inhibition may contribute to 4-hydroxytamoxifen sensitization in the breast cancer lines MCF7 and T47D (117).